Clinical Trial Update: Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS) [NA]

View source ↗

Summary

The University of Michigan–sponsored clinical trial studying cervical spinal cord metabolism and microstructure in Amyotrophic Lateral Sclerosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: University of Michigan | Conditions: Amyotrophic Lateral Sclerosis | NA | Status: TERMINATED